Terms: = Prostate cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Treatment
11 results:
1. Mechanism of Antitumor Effects of Saffron in Human prostate cancer Cells.
Khan M; Hearn K; Parry C; Rasid M; Brim H; Ashktorab H; Kwabi-Addo B
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201944
[TBL] [Abstract] [Full Text] [Related]
2. A new horizon for the old antibacterial drug clofoctol.
Bailly C; Vergoten G
Drug Discov Today; 2021 May; 26(5):1302-1310. PubMed ID: 33581321
[TBL] [Abstract] [Full Text] [Related]
3. Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Shrestha R; Llaurado Fernandez M; Dawson A; Hoenisch J; Volik S; Lin YY; Anderson S; Kim H; Haegert AM; Colborne S; Wong NKY; McConeghy B; Bell RH; Brahmbhatt S; Lee CH; DiMattia GE; Le Bihan S; Morin GB; Collins CC; Carey MS
Cancer Res; 2021 Apr; 81(7):1681-1694. PubMed ID: 33441310
[TBL] [Abstract] [Full Text] [Related]
4. Liquid Biopsy to Identify Actionable Genomic Alterations.
Ou SI; Nagasaka M; Zhu VW
Am Soc Clin Oncol Educ Book; 2018 May; 38():978-997. PubMed ID: 30231331
[TBL] [Abstract] [Full Text] [Related]
5. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H; van der Vos KE; Niedworok C; Herold T; Módos O; Szendrői A; Hager T; Ingenwerth M; Vis DJ; Behrendt MA; de Jong J; van der Heijden MS; Peyronnet B; Mathieu R; Wiesweg M; Ablat J; Okon K; Tolkach Y; Keresztes D; Nagy N; Bremmer F; Gaisa NT; Chlosta P; Kriegsmann J; Kovalszky I; Timar J; Kristiansen G; Radzun HJ; Knüchel R; Schuler M; Black PC; Rübben H; Hadaschik BA; Schmid KW; van Rhijn BWG; Nyirády P; Szarvas T
Int J Cancer; 2018 Oct; 143(7):1764-1773. PubMed ID: 29672836
[TBL] [Abstract] [Full Text] [Related]
6. A novel series of N-(pyridin-2-yl)-4-(thiazol-5-yl)pyrimidin-2-amines as highly potent CDK4/6 inhibitors.
Tadesse S; Zhu G; Mekonnen LB; Lenjisa JL; Yu M; Brown MP; Wang S
Future Med Chem; 2017 Sep; 9(13):1495-1506. PubMed ID: 28795589
[TBL] [Abstract] [Full Text] [Related]
7. A transcriptional target of androgen receptor, miR-421 regulates proliferation and metabolism of prostate cancer cells.
Meng D; Yang S; Wan X; Zhang Y; Huang W; Zhao P; Li T; Wang L; Huang Y; Li T; Li Y
Int J Biochem Cell Biol; 2016 Apr; 73():30-40. PubMed ID: 26827675
[TBL] [Abstract] [Full Text] [Related]
8. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3).
Senthilkumar K; Arunkumar R; Elumalai P; Sharmila G; Gunadharini DN; Banudevi S; Krishnamoorthy G; Benson CS; Arunakaran J
Cell Biochem Funct; 2011 Mar; 29(2):87-95. PubMed ID: 21308698
[TBL] [Abstract] [Full Text] [Related]
9. CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients.
Salnikov AV; Gladkich J; Moldenhauer G; Volm M; Mattern J; Herr I
Int J Cancer; 2010 Feb; 126(4):950-8. PubMed ID: 19676044
[TBL] [Abstract] [Full Text] [Related]
10. Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.
Wang Y; Shao C; Shi CH; Zhang L; Yue HH; Wang PF; Yang B; Zhang YT; Liu F; Qin WJ; Wang H; Shao GX
Asian J Androl; 2005 Dec; 7(4):375-80. PubMed ID: 16281084
[TBL] [Abstract] [Full Text] [Related]
11. International comparison on ras gene mutations in latent prostate carcinoma.
Watanabe M; Shiraishi T; Yatani R; Nomura AM; Stemmermann GN
Int J Cancer; 1994 Jul; 58(2):174-8. PubMed ID: 8026877
[TBL] [Abstract] [Full Text] [Related]
